Clinical Trial Update: Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating intravitreal diclofenac versus bevacizumab (Avastin) as initial treatment in patients with diffuse diabetic macular edema…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Avastin (bevacizumab)
• Diclofenac (diclofenac)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Diffuse Diabetic Macular Edema | Phase 1 | Status: UNKNOWN